Syncrosome News

Syncrosome will attend the Next BioConvention in Philadelphia, USA

Syncrosome at Bio2019 Come and meet Syncrosome at #BIO2019 booth #2109. Syncrosome invites you to visit us at BioConvention, June 3rd to June 7th 2016, in Philadelphia, USA. Emmanuelle Bettendorf, our Account Manager would be delighted to meet you their and discuss your in vivo preclinical projects. We...

Syncrosome will be pleased to meet you at Frankfurt during the 6th DDIP Congress

The 6ThDrug Discovery Innovation Programme will feature 2 days of interactive presentations, poster presentation and networking opportunity, in Frankfurt (Germany) from 29 to 30thof October. This conference will offer a complete programme focusing on preclinical animal models, breakthrough technologies : Target engagement Advances in medicinal...

Nordic Day Syncrosome

The last january, all the Syncrosome laboratory an commercial team participated on a 2-day team building event in the French Alpes. It was an enthusiastic "scientific and sportive" experience for everyone! After different meetings to exchange on topics like: Important scientific and commercial results obtained in 2016, ...

Syncrosome in French Alpes for a Special Nordic Team Event

  January 2017 is a great month for all the Syncrosome Laboratory and Commercial team. On Sunday 29th of January, all the team will be leaving for the French Alpes on a 2-day Team building experience. Our goal is to summarize Syncrosome’s 2016 life and events to...

Syncrosome: what did we change in 2016?

The end of 2016 is near, and with the closure of this year comes the joy of Christmas, holidays and celebrations, but before we head off to spend time with our families, we would like to thank you for your devotion throughout 2016. Let’s remember...

SYNCROSOME CIR accreditation

  For more than 6 years now, Syncrosome has worked as a preclinical CRO accredited by the French Ministry of Higher Education and Research for Research Tax Credits (CIR). Our recognition procures a significant financial benefit for French companies wishing to pursue their R & D work in Cardiovascular, Central...